-
Lipo3K Transfection Reagent: Evidence & Workflow
2026-08-14
Lipo3K Transfection Reagent is a lipid transfection reagent for DNA, siRNA, and mRNA delivery across adherent, suspension, and difficult-to-transfect cells. Product information reports high efficiency, low cytotoxicity, serum compatibility, and a plasmid-specific Lipo3K-A enhancer, while independent peer-reviewed evidence cited here provides biological context rather than a direct Lipo3K performance benchmark.
-
Z-YVAD-FMK: Reliable Caspase-1 Assays
2026-08-14
Learn how Z-YVAD-FMK (SKU A8955) can help distinguish caspase-1-dependent pyroptosis from apoptosis, ferroptosis, and nonspecific viability loss. This scenario-driven guide covers assay compatibility, DMSO preparation, interpretation, and practical product-selection criteria.
-
Spiroplasma Entry into Drosophila S2 Cells
2026-08-13
The reference study establishes a Drosophila Schneider 2-cell model for Spiroplasma eriocheiris infection and shows that bacterial entry depends mainly on clathrin-mediated endocytosis and macropinocytosis. Its inhibitor-based experiments further connect intracellular infection with actin filament and microtubule integrity, providing a useful framework for dissecting host–pathogen interactions in invertebrate cells.
-
Dibutyryl-cAMP, Sodium Salt in Neuronal Assays
2026-08-13
Dibutyryl-cAMP, sodium salt provides a practical way to elevate intracellular cAMP while tracking PKA-linked signaling during neuronal conversion and nuclear remodeling. This guide connects DBcAMP sodium salt dosing, assay controls, and troubleshooting with the ASCL1–NUP37 findings reported in a 2026 transdifferentiation study.
-
AO/PI Staining Solution for Mechanistic Cell Counting
2026-08-12
Discover how AO/PI Staining Solution converts membrane integrity into a more reliable live/dead cell discrimination workflow for diabetic nephropathy research. This evidence-focused guide connects fluorescence-based cell counting with the mechanistic findings of a recent phillygenin study while defining what the assay can—and cannot—prove.
-
USP7–PKM2 Control of Macrophages in Pancreatitis
2026-08-12
The 2025 Cell Death and Disease study identifies USP7 as a metabolic regulator of macrophage polarization in severe acute pancreatitis by controlling PKM2 deubiquitination, phosphorylation, and nuclear localization. Its genetic and pharmacological experiments connect PKM2-dependent glycolytic reprogramming with pancreatic inflammation, while also defining important limits for translating this mechanism to oncology or other disease models.
-
4-MUG: Measuring GCase in mRNA Therapy Models
2026-08-11
4-Methylumbelliferyl-β-D-Glucopyranoside enables sensitive measurement of glycosidase function, but its greatest value emerges when assay design separates catalytic activity from lysosomal restoration. This guide shows how to deploy 4-MUG in Gaucher disease and GBA1-mRNA research with stronger controls and more informative interpretation.
-
Topotecan HCl Workflow for Cancer Research
2026-08-11
Topotecan HCl supports mechanistic studies that connect replication-associated DNA damage with measurable growth inhibition and cell death. This workflow shows how to select exposure schedules, separate viability from killing, and troubleshoot solvent, timing, and model-specific variability.
-
Antimycin A4: Metabolic Assay Workflows
2026-08-10
Antimycin A4 combines ATP-citrate lyase inhibition with mitochondrial respiratory-chain blockade, making it useful for separating lipid-biosynthesis effects from cellular energy failure. This guide provides practical biochemical and cell-based workflows, control strategies, and troubleshooting advice for using the compound as an energy metabolism research tool.
-
Probenecid: MRP Inhibition and Neuroprotection
2026-08-09
Probenecid, also known as 4-(dipropylsulfamoyl)benzoic acid, is an experimental inhibitor of organic anion transporters, multidrug resistance-associated proteins, and pannexin-1 channels. Product and model-system evidence supports its use in multidrug resistance reversal in leukemia and in studies of neuroprotection in cerebral ischemia/reperfusion injury, but the compound does not establish a universal mechanism or clinical treatment effect.
-
Intravesical p21 mRNA-LNP Therapy for Bladder Cancer
2026-08-08
This FASEB Journal study develops a localized, nonviral strategy for bladder cancer by delivering chemically modified p21 mRNA in lipid nanoparticles through intravesical instillation. The work links restored nuclear p21 expression to cell-cycle suppression, DNA-damage signaling, apoptosis, and reduced tumor growth in an orthotopic mouse model, while highlighting the translational value of organ-directed mRNA delivery.
-
Macrophage EV miR-660 Drives Breast Cancer Metastasis
2026-08-07
The reference study identifies tumor-associated macrophage extracellular vesicles as carriers of miR-660 that enhance breast cancer invasion through the KLHL21–IKKβ–NF-κB p65 axis. Its combination of patient-tissue analysis, gain- and loss-of-function experiments, extracellular-vesicle tracing, and mouse metastasis models provides a mechanistic framework for studying macrophage–tumor communication.
-
Romidepsin (FK228) in Applied Epigenetic Cancer Research
2026-08-07
Romidepsin (FK228) stands out as a highly selective HDAC inhibitor, offering precision in cancer epigenetic studies and apoptosis assays. This guide details optimized experimental protocols, troubleshooting strategies, and actionable insights inspired by recent multidimensional proteomics, enabling researchers to harness Romidepsin’s full potential in translational oncology.
-
Reliable CRISPR Editing with EZ Cap™ Cas9 mRNA (m1Ψ): Lab-Dr
2026-08-06
Discover how EZ Cap™ Cas9 mRNA (m1Ψ) (SKU R1014) addresses common genome editing pitfalls in mammalian cell assays. This scenario-driven analysis details how Cap1 structure and m1Ψ modification improve specificity, suppress immune activation, and streamline workflow reliability for biomedical researchers.
-
Recombinant Human Oncostatin M: Advanced Workflows in Cell B
2026-08-06
APExBIO’s Recombinant Human Oncostatin M (E.coli, Tag Free, Lyophilized) empowers researchers with unmatched reproducibility across fibroblast, smooth muscle, and tumor cell modulation assays. This article unpacks optimized protocols, troubleshooting strategies, and translational insights, leveraging the latest advances in radiotherapy resistance research.